SUPPORT: 48-week results of fosamprenavir-ritonavir vs efavirenz with abacavir-lamivudine in under-represented, antiretroviral-naïve patientsReport as inadecuate




SUPPORT: 48-week results of fosamprenavir-ritonavir vs efavirenz with abacavir-lamivudine in under-represented, antiretroviral-naïve patients - Download this document for free, or read online. Document in PDF available to download.

Journal of the International AIDS Society

, 13:P7

First Online: 08 November 2010DOI: 10.1186-1758-2652-13-S4-P7

Cite this article as: Kumar, P., DeJesus, E., Huhn, G. et al. JIAS 2010 13Suppl 4: P7. doi:10.1186-1758-2652-13-S4-P7 Download fulltext PDF



Author:

Source: https://link.springer.com/







Related documents